Financier | Commitments |
---|---|
International Bank for Reconstruction and Development | 400.00 |
Indonesia - Free-standing Trust Fund Program | 2.33 |
P172707
Active
Zelalem Debebe , Eko Pambudi, Somil Nagpal
Republic of Indonesia
July 12, 2020
(as of board presentation)
December 15, 2021
May 17, 2022
US$ 18752.33 million
BPJS- Kesehatan,Ministry of Health,Dewan Jaminan Sosial Nasional (DJSN),Ministry of Finance
2022
US$ 402.33 million
N/A
June 13, 2024
September 30, 2026
No
BANK APPROVED
Financier | Commitments |
---|---|
International Bank for Reconstruction and Development | 400.00 |
Indonesia - Free-standing Trust Fund Program | 2.33 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | 400.00 |
IDA Commitment | N/A |
IBRD + IDA Commitment | 400.00 |
Lending Instrument | |
---|---|
Grant Amount | 2.33 |
Total Project Cost** | 18752.33 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Feb 1, 2024 | IBRD-93160 | Int Charges | 3,218,669.00 |
Aug 1, 2024 | IBRD-93160 | Int Charges | 4,660,697.50 |
Aug 1, 2024 | IBRD-93160 | Int Charges | 20,688.06 |
Aug 1, 2024 | IBRD-93160 | Int Charges | 317,818.06 |
Jul 28, 2022 | IBRD-93160 | Loan Disb | 100,000,000.00 |
Jul 16, 2022 | IBRD-93160 | Fee Charges | 1,000,000.00 |
Feb 1, 2023 | IBRD-93160 | Int Charges | 378,082.20 |
Feb 1, 2023 | IBRD-93160 | Int Charges | 2,185,289.20 |
Aug 1, 2023 | IBRD-93160 | Int Charges | 85,413.71 |
Aug 1, 2023 | IBRD-93160 | Int Charges | 371,917.80 |
Aug 1, 2023 | IBRD-93160 | Int Charges | 2,754,628.00 |
Feb 1, 2023 | IBRD-93160 | Int Charges | 41,095.89 |
Feb 1, 2023 | IBRD-93160 | Int Charges | 38,251.57 |
Feb 1, 2024 | IBRD-93160 | Int Charges | 23,313.11 |
Feb 1, 2024 | IBRD-93160 | Int Charges | 377,908.16 |
Dec 15, 2021 | IBRD-93160 | Loan Commitment | 400,000,000.00 |
Feb 27, 2024 | IBRD-93160 | Loan Disb | 51,740,000.00 |
Name | Review | Date |
---|---|---|
Monitoring and Evaluation | Moderately Satisfactory | 2024-12-20 |
Monitoring and Evaluation | Satisfactory | 2024-12-20 |
Overall Implementation Progress (IP) | Satisfactory | 2024-12-20 |
Progress towards achievement of PDO | Moderately Satisfactory | 2024-12-20 |
Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-12-20 |
Progress towards achievement of PDO | Moderately Satisfactory | 2024-12-20 |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Increase in the % of outpatient utilization among bottom two quintiles | Value | 13.20 | 8.50 | 15.20 |
Date | December 31, 2019 | March 31, 2023 | December 31, 2026 | |
Comment |
Improved provider competency score in FKTPs | Value | To be determined in 2024 | Not yet determined | Increased above baseline values for at least 70 pe |
Date | December 31, 2024 | May 27, 2024 | December 31, 2026 | |
Comment |
More sustainable claims ratio | Value | 102% | 105% | <98% |
Date | December 31, 2019 | December 29, 2023 | December 31, 2026 | |
Comment |
Improved member satisfaction rate and its continued use as a BPJS-K performance monitoring indicator | Value | 81.5% | 89.6% | Above 82%(and continued as BPJS performance indic |
Date | December 31, 2019 | December 30, 2022 | December 31, 2026 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Decrease in the % of claims that were pending settlement for more than 14 days | Value | 2.57 | To be determined | To be determined |
Date | June 30, 2023 | December 19, 2023 | December 31, 2026 | |
Comment |
Improved policy formulation and oversight of JKN | Value | NA | 0 | Annual report for previous year published |
Date | October 1, 2021 | May 31, 2024 | December 31, 2026 | |
Comment |
Number of clinical diagnostic, treatment, or referral guidelines formulated into processes of care for FKRTLs | Value | 0.00 | 10.00 | 20.00 |
Date | October 1, 2021 | May 31, 2024 | December 31, 2026 | |
Comment |
Number of additional performance and quality indicators included in primary care payment system | Value | 3.00 | 3.00 | 13.00 |
Date | October 1, 2021 | May 31, 2024 | December 31, 2026 | |
Comment |
Increase in the % of antenatal care visits in-line with clinical protocols disaggregated by province | Value | Baseline in Year 2024 | Delayed due to DLI 1. Baseline in Year 2024 | To be determined |
Date | December 19, 2023 | May 31, 2024 | December 31, 2026 | |
Comment |
Cumulative number of FKRTLs with trained and certified clinical coders | Value | 0.00 | 567.00 | 1800.00 |
Date | October 1, 2021 | January 31, 2024 | December 31, 2026 | |
Comment |
Number of maternal deaths caused by hypertension disaggregated by province | Value | 1066 | 1010 | <900 |
Date | October 1, 2021 | December 29, 2023 | December 31, 2026 | |
Comment |
Increase in the % of adults screened for diabetes and hypertension in-line with clinical protocols | Value | Baseline in year 2024 | Delayed due to DLI 1. Baseline in Year 2024 | To be determined |
Date | December 31, 2024 | May 31, 2024 | December 31, 2026 | |
Comment |
Improved provider competency on maternal care disaggregated | Value | Baseline to be determined | Not yet due. DLI 1 linked. Baseline to be determin | The competence scores are increased for at least 7 |
Date | December 31, 2024 | May 31, 2024 | December 31, 2026 | |
Comment |
Recommended tracer indicators embedded and automated in the claims verification software to monitor compliance with evidence-based care | Value | 0 | Delayed due to DLI 1 &2 | 25 (15 for FKTP and 10 for FKRTL) |
Date | October 1, 2021 | May 31, 2024 | December 31, 2026 | |
Comment |
Number of information systems integrated as per roadmap target | Value | 0 | 3 | To be determined by roadmap |
Date | October 1, 2021 | May 31, 2024 | December 31, 2026 | |
Comment |
Share of FKTPs trained in using the clinical decision support tool | Value | 0.00 | 0.00 | 90.00 |
Date | October 1, 2021 | May 31, 2024 | December 31, 2025 | |
Comment |